These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 34174329)

  • 1. The Intrinsically Disordered Proteins MLLT3 (AF9) and MLLT1 (ENL) - Multimodal Transcriptional Switches With Roles in Normal Hematopoiesis, MLL Fusion Leukemia, and Kidney Cancer.
    Kabra A; Bushweller J
    J Mol Biol; 2022 Jan; 434(1):167117. PubMed ID: 34174329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural studies of intrinsically disordered MLL-fusion protein AF9 in complex with peptidomimetic inhibitors.
    Yang Y; Ahmad E; Premkumar V; Liu A; Ashikur Rahman SM; Nikolovska-Coleska Z
    Protein Sci; 2024 Jun; 33(6):e5019. PubMed ID: 38747396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The YEATS domain epigenetic reader proteins ENL and AF9 and their therapeutic value in leukemia.
    Hu H; Muntean AG
    Exp Hematol; 2023 Aug; 124():15-21. PubMed ID: 37295550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-molecule inhibitor of AF9/ENL-DOT1L/AF4/AFF4 interactions suppresses malignant gene expression and tumor growth.
    Wu F; Nie S; Yao Y; Huo T; Li X; Wu X; Zhao J; Lin YL; Zhang Y; Mo Q; Song Y
    Theranostics; 2021; 11(17):8172-8184. PubMed ID: 34373735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a Selective Inhibitor for the YEATS Domains of ENL/AF9.
    Christott T; Bennett J; Coxon C; Monteiro O; Giroud C; Beke V; Felce SL; Gamble V; Gileadi C; Poda G; Al-Awar R; Farnie G; Fedorov O
    SLAS Discov; 2019 Feb; 24(2):133-141. PubMed ID: 30359161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collaboration of MLLT1/ENL, Polycomb and ATM for transcription and genome integrity.
    Ui A; Yasui A
    Nucleus; 2016 Apr; 7(2):138-45. PubMed ID: 27310306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ENL: structure, function, and roles in hematopoiesis and acute myeloid leukemia.
    Zhou J; Ng Y; Chng WJ
    Cell Mol Life Sci; 2018 Nov; 75(21):3931-3941. PubMed ID: 30066088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MLLT1 YEATS domain mutations in clinically distinctive Favourable Histology Wilms tumours.
    Perlman EJ; Gadd S; Arold ST; Radhakrishnan A; Gerhard DS; Jennings L; Huff V; Guidry Auvil JM; Davidsen TM; Dome JS; Meerzaman D; Hsu CH; Nguyen C; Anderson J; Ma Y; Mungall AJ; Moore RA; Marra MA; Mullighan CG; Ma J; Wheeler DA; Hampton OA; Gastier-Foster JM; Ross N; Smith MA
    Nat Commun; 2015 Dec; 6():10013. PubMed ID: 26635203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification.
    Mueller D; Bach C; Zeisig D; Garcia-Cuellar MP; Monroe S; Sreekumar A; Zhou R; Nesvizhskii A; Chinnaiyan A; Hess JL; Slany RK
    Blood; 2007 Dec; 110(13):4445-54. PubMed ID: 17855633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting recruitment of disruptor of telomeric silencing 1-like (DOT1L): characterizing the interactions between DOT1L and mixed lineage leukemia (MLL) fusion proteins.
    Shen C; Jo SY; Liao C; Hess JL; Nikolovska-Coleska Z
    J Biol Chem; 2013 Oct; 288(42):30585-30596. PubMed ID: 23996074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukemia fusion target AF9 is an intrinsically disordered transcriptional regulator that recruits multiple partners via coupled folding and binding.
    Leach BI; Kuntimaddi A; Schmidt CR; Cierpicki T; Johnson SA; Bushweller JH
    Structure; 2013 Jan; 21(1):176-183. PubMed ID: 23260655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The leukemia-associated gene Mllt1/ENL: characterization of a murine homolog and demonstration of an essential role in embryonic development.
    Doty RT; Vanasse GJ; Disteche CM; Willerford DM
    Blood Cells Mol Dis; 2002; 28(3):407-17. PubMed ID: 12367585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of an MLLT1/3 YEATS Domain Chemical Probe.
    Moustakim M; Christott T; Monteiro OP; Bennett J; Giroud C; Ward J; Rogers CM; Smith P; Panagakou I; Díaz-Sáez L; Felce SL; Gamble V; Gileadi C; Halidi N; Heidenreich D; Chaikuad A; Knapp S; Huber KVM; Farnie G; Heer J; Manevski N; Poda G; Al-Awar R; Dixon DJ; Brennan PE; Fedorov O
    Angew Chem Int Ed Engl; 2018 Dec; 57(50):16302-16307. PubMed ID: 30288907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of PFI-6, a small-molecule chemical probe for the YEATS domain of MLLT1 and MLLT3.
    Raux B; Buchan KA; Bennett J; Christott T; Dowling MS; Farnie G; Fedorov O; Gamble V; Gileadi C; Giroud C; Huber KVM; Korczynska M; Limberakis C; Narayanan A; Owen DR; Sáez LD; Stock IA; Londregan AT
    Bioorg Med Chem Lett; 2024 Jan; 98():129546. PubMed ID: 37944866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIRT2 regulates proliferation and chemotherapy response of MLL-ENL-driven acute myeloid leukemia.
    Hao C; Shao X; Song J; Peng M; Lao Y; Mack R; Zhang L; Wei W; Liu N; Wang T; Wu Y; Feng L; Yin L; Wang S; Sun X; Chen S; Zhang J; Li B
    Biochem Biophys Res Commun; 2022 Mar; 596():36-42. PubMed ID: 35108652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Polymerase-Associated Factor complex (PAFc) connects the Super Elongation Complex (SEC) to RNA polymerase II on chromatin.
    He N; Chan CK; Sobhian B; Chou S; Xue Y; Liu M; Alber T; Benkirane M; Zhou Q
    Proc Natl Acad Sci U S A; 2011 Sep; 108(36):E636-45. PubMed ID: 21873227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCOR Binding to MLL-AF9 Is Essential for Leukemia via Altered EYA1, SIX, and MYC Activity.
    Schmidt CR; Achille NJ; Kuntimaddi A; Boulton AM; Leach BI; Zhang S; Zeleznik-Le NJ; Bushweller JH
    Blood Cancer Discov; 2020 Sep; 1(2):162-177. PubMed ID: 32954361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ENL YEATS epigenetic reader domain critically links MLL-ENL to leukemic stem cell frequency in t(11;19) Leukemia.
    Hu H; Saha N; Yang Y; Ahmad E; Lachowski L; Shrestha U; Premkumar V; Ropa J; Chen L; Teahan B; Grigsby S; Marschalek R; Nikolovska-Coleska Z; Muntean AG
    Leukemia; 2023 Jan; 37(1):190-201. PubMed ID: 36435883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YEATS domain proteins: a diverse family with many links to chromatin modification and transcription.
    Schulze JM; Wang AY; Kobor MS
    Biochem Cell Biol; 2009 Feb; 87(1):65-75. PubMed ID: 19234524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia.
    Monroe SC; Jo SY; Sanders DS; Basrur V; Elenitoba-Johnson KS; Slany RK; Hess JL
    Exp Hematol; 2011 Jan; 39(1):77-86.e1-5. PubMed ID: 20854876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.